| Trade name of the product: |
| Kytril |
| Pharmaceutical active ingredients: |
| Granisetron Hydrochloride |
| Available forms, composition and doses of Kytril: |
| Injectable; Injection; Granisetron Hydrochloride 1 mg / mlSolution; Oral; Granisetron Hydrochloride 0.2 mg / mlTablets, Film-Coated; Oral; Granisetron Hydrochloride 1 mgTablets, Film-Coated; Oral; Granisetron Hydrochloride 2 mgTablets; Oral; Granisetron Hydrochloride 1 mgTablets; Oral; Granisetron Hydrochloride 2 mg |
| Medical categories: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA02 - Granisetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RocheDKSHGenentechGlaxoSmithKlineMayne PharmaZuellig Pharma |
| Related documents and information about Kytril: |
| Kytril injection prescribing information (PDF)Kytril tablets and oral solution prescribing information (PDF) |